Silvant Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $167K | Hold |
1,932
| – | – | 0.01% | 204 |
|
|
2025
Q4 | $186K | Hold |
1,932
| – | – | 0.01% | 192 |
|
|
2025
Q3 | $184K | Hold |
1,932
| – | – | 0.01% | 192 |
|
|
2025
Q2 | $168K | Hold |
1,932
| – | – | 0.01% | 186 |
|
|
2025
Q1 | $174K | Hold |
1,932
| – | – | 0.01% | 182 |
|
|
2024
Q4 | $154K | Hold |
1,932
| – | – | 0.01% | 189 |
|
|
2024
Q3 | $175K | Hold |
1,932
| – | – | 0.01% | 181 |
|
|
2024
Q2 | $153K | Hold |
1,932
| – | – | 0.01% | 187 |
|
|
2024
Q1 | $170K | Hold |
1,932
| – | – | 0.01% | 189 |
|
|
2023
Q4 | $160K | Hold |
1,932
| – | – | 0.01% | 183 |
|
|
2023
Q3 | $153K | Hold |
1,932
| – | – | 0.01% | 184 |
|
|
2023
Q2 | $172K | Hold |
1,932
| – | – | 0.01% | 178 |
|
|
2023
Q1 | $157K | Sell |
1,932
-17,916
| -90% | -$1.46M | 0.01% | 175 |
|
|
2022
Q4 | $1.56M | Sell |
19,848
-5,712
| -22% | -$463K | 0.11% | 118 |
|
|
2022
Q3 | $2.08M | Sell |
25,560
-236
| -0.9% | -$21.2K | 0.14% | 103 |
|
|
2022
Q2 | $2.33M | Sell |
25,796
-350
| -1% | -$35.5K | 0.57% | 45 |
|
|
2022
Q1 | $2.92M | Sell |
26,146
-671
| -3% | -$70.9K | 0.56% | 45 |
|
|
2021
Q4 | $2.79M | Sell |
26,817
-1,477
| -5% | -$171K | 0.48% | 51 |
|
|
2021
Q3 | $3.56M | Sell |
28,294
-5,047
| -15% | -$653K | 0.64% | 37 |
|
|
2021
Q2 | $4.16M | Sell |
33,341
-690
| -2% | -$86.6K | 0.66% | 35 |
|
|
2021
Q1 | $4.04M | Hold |
34,031
| – | – | 0.69% | 34 |
|
|
2020
Q4 | $4.01M | Sell |
34,031
-150
| -0.4% | -$16.5K | 0.68% | 32 |
|
|
2020
Q3 | $3.57M | Sell |
34,181
-607
| -2% | -$61K | 0.67% | 34 |
|
|
2020
Q2 | $3.21M | Hold |
34,788
| – | – | 0.58% | 40 |
|
|
2020
Q1 | $3.16M | Hold |
34,788
| – | – | 0.69% | 35 |
|
|
2019
Q4 | $3.96M | Sell |
34,788
-170
| -0.5% | -$18.7K | 0.72% | 35 |
|
|
2019
Q3 | $3.82M | Sell |
34,958
-426
| -1% | -$44.4K | 0.75% | 34 |
|
|
2019
Q2 | $3.45M | Sell |
35,384
-265
| -0.7% | -$24.2K | 0.62% | 50 |
|
|
2019
Q1 | $3.26M | Sell |
35,649
-185
| -0.5% | -$16.6K | 0.59% | 50 |
|
|
2018
Q4 | $3.28M | Sell |
35,834
-39,476
| -52% | -$3.69M | 0.66% | 50 |
|
|
2018
Q3 | $7.45M | Sell |
75,310
-527
| -0.7% | -$48.7K | 0.92% | 30 |
|
|
2018
Q2 | $6.49M | Buy |
75,837
+939
| +1% | +$78.4K | 0.8% | 36 |
|
|
2018
Q1 | $6.04M | Buy |
+74,898
| New | +$6.18M | 0.78% | 40 |
|
Other funds holding MDT
VCM
VPM
Silvant Capital Management's MDT Position: Q1 2026 in Review
Silvant Capital Management held its Medtronic (MDT) position steady in Q1 2026 at 1,932 shares worth $167K. The position accounts for 0.01% of the portfolio, ranked #204.
Silvant Capital Management first reported a position in MDT in Q1 2018 and has held it in 33 quarters since. The position peaked at $7.45M in Q3 2018. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Silvant Capital Management held 1,932 shares of Medtronic worth $167K as of Q1 2026.
- Silvant Capital Management left its Medtronic share count unchanged in Q1 2026.
- Medtronic made up 0.01% of Silvant Capital Management's portfolio in Q1 2026, its #204 holding.
- Silvant Capital Management first reported a position in Medtronic in Q1 2018 and has held it in 33 quarters since.
- Silvant Capital Management's Medtronic position peaked at $7.45M in Q3 2018.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Silvant Capital Management's 13F filing for Q1 2026, filed 14 May 2026.